HilleVax, Inc.
HLVX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $2 | $5 | $20 |
| G&A Expenses | $6 | $6 | $6 | $6 |
| SG&A Expenses | $6 | $6 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $25 | $0 |
| Operating Expenses | $7 | $8 | $36 | $26 |
| Operating Income | -$7 | -$8 | -$36 | -$26 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | $2 | $2 | $1 |
| Pre-Tax Income | -$5 | -$6 | -$34 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$34 | -$26 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.68 | -0.52 |
| % Growth | 8.3% | 82.4% | -30.8% | – |
| EPS Diluted | -0.11 | -0.12 | -0.68 | -0.52 |
| Weighted Avg Shares Out | 50 | 50 | 50 | 49 |
| Weighted Avg Shares Out Dil | 50 | 50 | 50 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $1 |
| Interest Expense | $0 | $0 | $0 | $2 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$5 | -$6 | -$33 | -$23 |
| % Margin | – | – | – | – |